Tuesday 15 January 2019

Electrosurgical Devices Market Growth Factors, Trends and Forecast Report to 2025:Grand View Research, Inc.


San Francisco, 15 January, Electrosurgical Devices Market Analysis By Method (Monopolar, Bipolar), By Product (Electrosurgical Generators, Active Electrodes, Dispersive Electrodes, Other Accessories), And Segment Forecasts, 2018 - 2025
The global electrosurgical devices market is expected to reach USD 7.2 billion in 2025, according to a new report by Grand View Research, Inc. Shifting focus of surgeons from conventional surgical procedures toward minimally invasive procedures, such as electrosurgery, and growing competition amongst the participants have high impact on the market’s growth. Entry of local companies in the developing regions is expected to fuel the global market due to availability of affordable equipment.
Electrosurgeries are preferred over conventional procedures owing to advantages such as improved safety and ease of use. These advantages enable the use of such surgeries in sensitive procedures such as those related to neurology and ophthalmology. Electrosurgery is being used in various disciplines, such as gynecology, urology, gastroenterology, and general surgery. In addition, latest electrosurgical equipment enables the performance of procedures outside the operating room. Thus, the demand for these equipment is expected to rise in various disciplines during the forecast period. The growth is expected to experience impediment due to factors such as lack of skilled professionals and high price of the devices. Furthermore, most of the electrosurgical devices are categorized as Class III devices, which take considerably longer time for approval.
Access Full Research Report On Electrosurgical Devices Market  Analysis:
www.grandviewresearch.com/industry-analysis/electrosurgical-devices-market

Further Key Findings From the Study Suggest:
·         The study suggests that bipolar segment captured the largest share in 2015 and is expected to dominate throughout the forecast period
·         Growing preference for bipolar electrosurgical devices over monopolar is a result of the advantages of the former, such as safe to use, convenience, and affordable prices. Monopolar equipment is still being used in minor surgeries and has the advantage of easy tissue cutting over bipolar equipment.
·         Active electrode segment captured the largest share in 2015 and is expected to witness highest growth rate as compared to other products
·         The introduction of innovative and technologically advanced electrodes and growing trends of using disposable electrodes are the factors driving the segment growth
·         North America dominated in 2015, with the U.S. capturing the largest share
·         Presence of a large number of players and high adoption rate of advanced medical devices are the factors driving growth in North America
·         Few of the major companies operating in the market include ATMOS, Inc.; Bovie Medical Corporation; Parkell, Inc.; Covidien plc; Olympus Corporation; Ethicon, Inc; Boston Scientific; B. Braun Melsungen AG; Kirwan Surgical Products, LLC; and Smith and Nephew.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the electrosurgical device market on the basis of method, product, and region:
Electrosurgical Devices Method Outlook (Revenue, USD Million, 2014 - 2025)
·         Monopolar
·         Bipolar
Electrosurgical Devices Product Outlook (Revenue, USD Million 2014 - 2025)
·         Electrosurgical Generators
·         Active Electrodes
·         Dispersive Electrodes
·         Other Accessories
Electrosurgical Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa


Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Cervical Cancer Diagnostic Market Growth Factors, Trends and Forecast Report to 2024:Grand View Research, Inc.


San Francisco, 15 January, Cervical Cancer Diagnostic Market Analysis By Test Type (Pap Testing Or Cytology Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy) And Segment Forecasts To 2024 .
The global cervical cancer diagnostic market was valued at USD 7 billion in 2015 and is expected to reach a value of USD 12 billion by 2024, according to a new report by Grand View Research, Inc. The key driving factors include the rising prevalence of cervical cancer, evolving screening technology, and various programs that promote routine check up and screening. According to the data published by the WHO, in 2012, over 270,000 women died due to cervical cancer, majority of which were from the developing countries. It is one of the most common cancer type diagnosed in women. Some of the etiological factors are multiple sex partners, and changing lifestyle, such as drinking & smoking and increased stress levels.
Furthermore, favorable government initiatives and increasing number of awareness programs are further expected to promote the market growth in coming few years. The National Cervical Cancer Coalition, WHO, CDC, the U.S. Preventive Services Task Force, are working towards promoting the necessity for early screening of cervical cancer amongst mid aged women.
There is an increasing demand for technologically advanced diagnostic procedures that facilitate the early intervention of the disease. The industry players are focused on developing innovative technological solutions for accurate and efficient results. Advancement in screening techniques, such as use of biomarkers, is gaining importance. The upsurge in technological developments is anticipated to further drive industry growth.
On account of increasing adoption of Pap test, the number of deaths due to cervical cancer has declined significantly in past few years. It helps detect precancerous lesions at an early state and, thus, reduces the number of cervical cancer cases. The American Cancer Society stated that the cervical cancer cases in last 40 years in the U.S. have declined by more than 50%. Initially, the Pap test screening was carried out every year which lead to further unnecessary procedures. However, the American Cancer Society now recommends that women in the age group of 21 to 29 should undergo Pap test every 3 years.
Access Full Research Report On Cervical Cancer Diagnostic Market  Analysis:

Further Key Findings from the Study Suggest:
·         In 2015, the Pap testing segment held majority of the market share of 49.6%. The segment’s large share can be attributed to the high efficiency of the tests in early diagnosis. Also, the increasing awareness about the impact of early diagnosis contributed to its growth.
·         In 2015, North America was the leading regional market with a revenue share of 48.3%. The U.S. is a key market in North America. Growing incidence of cervical cancer coupled with initiatives undertaken by government agencies in the form of awareness programs pertaining to the early screening of the disease are key factors for the country’s large market share.
·         Asia Pacific is expected to witness lucrative growth over the forecast period growing at a CAGR of 9.6%. The various steps undertaken by governments of developing countries such as India, China, Philippines, and other in order to improve healthcare infrastructure and to improve access to healthcare facilities are amongst key factors attributing to region’s high growth. Also, high prevalence of cancer in developing nations and increasing consumer awareness levels drive the growth
·         This market is presently dominated by a few key participants such as Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, OncoHealth Corp, Hologic, Inc., QIAGEN, Quest Diagnostics, Inc and Guided Therapeutics, Inc. The key players focus specially on developing innovative solutions for diagnosis. For instance, F. Hoffmann-La Roche Ltd., in 2014, launched automated CINtec PLUS cytology test that efficiently detects the presence of precancerous cells.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the Cervical cancer diagnostic market by outsourcing services, application, end use, and region:
Test type outlook (Market revenue in USD Billion, 2013 - 2024)
·         Pap Testing
·         HPV Testing
·         Colposcopy
·         Cervical Biopsies
·         Cystoscopy
Regional outlook (Market revenue in USD Billion, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa
o    South Africa

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Cellular IoT Market Growth Factors, Trends and Forecast Report to 2025:Grand View Research, Inc.



San Francisco, 15 January, Cellular IoT Market Analysis By Component (Hardware, Software), By Type (2G, 3G, 4G, LTE-M, NB-LTE-M, NB-IoT, 5G), By End-use, By Region, And Segment Forecasts, 2018 – 2025

The global cellular IoT market is expected to reach USD 9.65 billion by 2025, according to a new study by Grand View Research, Inc. The hype around Internet of Things (IoT) and its tremendous potential to revolutionize machine-to-machine and machine-to-human communications has reached its peak, owing to which numerous technology vendors are prodding different variants of emerging technologies to capitalize on this opportunity. With increased pervasiveness of cellular connectivity and the ready availability of its extensive networks, mobile broadband is anticipated to gain unprecedented significance in IoT.
An important aspect of the growth of cellular IoT is its ability to leverage mobility and range as compared to other IoT access methods, which can be the major differentiating factor over its contemporary service delivery techniques. In addition, cellular networks operate on the existing network infrastructure and offer reliable and quality services with assured security, which would play a vital role in their adoption in both industrial and consumer applications.
While cellular IoT primarily operates on the LTE technology, the emergence of other Low Power Wide Area Networks (LPWAN), such as LoRA and SigFox, and comparatively higher costs of cellular modules may hinder the market growth in the next couple of years. The role played by emerging technologies such as NarrowBand-IoT and NarrowBand-LTE-M will be instrumental in the hustle for gaining M2M market share. These technologies are specifically designed for IoT applications and are on the verge of commercialization with numerous pilot projects being launched in different parts of the world.
Cellular IoT offers numerous advantages such as broader coverage, deep indoor penetration, and smaller module size, owing to which it is largely preferred in high-density deployments. This is also expected to aid in the increased adoption of the technology over the next decade. Furthermore, cellular technologies, especially LTE, are supported and backed by a consortium of established industry players and various organizations such as 3rd Generation Partnership Project (3GPP) and Global System for Mobile Association (GSMA), which is expected to boost the market growth in the coming years.
Access Full Research Report On Cellular IoT Market  Analysis:

Further key findings from the study suggest:
·         North America is expected to maintain its dominant position in the global market owing to a greater penetration of next-generation LTE technologies, especially in the U.S.
·         2G holds the largest market share in terms of revenue generated; however, it is expected to gradually lose its share to emerging technologies, such as 4G, LTE-M, and NB-IoT. An interesting factor about the competing technologies, is the way in which these technologies operate in relation to each other (LTE-M vs NB-LTE-M vs NB-IoT) and whether they act as complementary or rival technologies in IoT
·         Standard bodies, including 3GPP, are actively promoting the usage of cellular IoT technology and network transformation in broadband connectivity, which is expected to drive market growth and standardization over the forecast period.
·         Remote monitoring, cloud connectivity, predictive maintenance, remote operation, and remote maintenance are some of the major applications being commercialized in different end-use industries.
·         Numerous applications of cellular IoT are anticipated to be the most important growth driver for the market with a phenomenal increase in device shipments over the forecast period.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/emerging-and-next-generation-technologies
Grand View Research has segmented the global cellular IoT market based on components, types, end uses, and regions:
Component Scope (Revenue, USD Million; 2014 - 2025)
·         Hardware
·         Software
o    Device Management
o    Signal Processing
Type Scope (Revenue, USD Million; 2014 - 2025)
·         2G
·         3G
·         4G
·         LTE-M
·         NB-LTE-M
·         NB-IoT
·         5G
End-use Scope (Revenue, USD Million; 2014 - 2025)
·         Agriculture
·         Automotive & Transportation
·         Consumer Electronics
·         Energy
·         Environment Monitoring
·         Healthcare
·         Retail
·         Smart Cities
·         Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    China
o    India
o    Japan
·         Latin America
o    Brazil
·         Middle East & Africa (MEA)

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/